Clinical trials
Diabetic Foot trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Terminated | 4 |
| Unknown status | 4 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aurealis Oy | 2 |
| ConvaTec Inc. | 2 |
| GWT-TUD GmbH | 2 |
| Pfizer | 2 |
| Ruhr University of Bochum | 2 |
| medac GmbH | 2 |
| AO Clinical Investigation and Publishing Documentation | 1 |
| AOTI Ltd. | 1 |
| Aposcience AG | 1 |
| BSN Medical GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Foot | 36 |
| Chronic Limb-Threatening Ischemia | 5 |
| Arterial Occlusive Diseases | 3 |
| Diabetes Mellitus | 3 |
| Ischemia | 3 |
| Leg Ulcer | 3 |
| Varicose Ulcer | 3 |
| Diabetes Complications | 2 |
| Foot Ulcer | 2 |
| Osteomyelitis | 2 |
Trials
Showing 51 to 36 of 36. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.